Is a Bone Marrow Biopsy Required for ET Diagnosis?

If you have a positive genetic test for a driver mutation (like JAK2, CALR, or MPL), a bone marrow biopsy is generally necessary for a formal, official diagnosis of essential thrombocythemia (ET) under current international guidelines ^[1].

However, the decision is ultimately a shared one between you and your doctor. While the biopsy is the only way to definitively confirm ET, in some situations—especially if a patient declines the procedure—a hematologist may establish a “provisional” or working diagnosis based on your blood tests and symptoms ^[2].

Why a Positive Genetic Test Isn’t Enough

Genetic tests are incredibly useful. Finding a driver mutation (a specific genetic change that triggers abnormal cell growth) strongly supports the possibility that your high platelet count is caused by a myeloproliferative neoplasm (MPN)—a chronic blood-forming-cell condition ^[3]. (It is important to note that a positive mutation does not entirely rule out secondary causes of high platelets, and a negative test does not rule out ET, as some patients are “triple negative” ^[4]).

However, a mutation alone does not establish which specific MPN you have. A JAK2 mutation, for instance, can also be found in almost all patients with polycythemia vera (PV) and in many patients with primary myelofibrosis (PMF) ^[5][1]. Because these related conditions can share common driver mutations, the blood test alone cannot tell your doctor exactly what is happening in your marrow ^[6].

What the Biopsy Actually Shows

To confidently diagnose ET, a hematopathologist (a doctor specializing in diagnosing blood diseases) must look at the bone marrow itself under a microscope—an analysis called bone marrow morphology ^[7]. The core biopsy is interpreted alongside your blood counts and molecular results. It provides information that blood tests cannot:

• Megakaryocyte Appearance: Megakaryocytes are the bone marrow cells that make platelets. In ET, these cells typically look enlarged and mature, and they group together in loose clusters ^[8]. In other MPNs, they look distinctly different ^[9].
• Baseline Fibrosis (Scarring): The biopsy allows your doctor to check for reticulin fibrosis (early scarring in the bone marrow). In ET, there is usually no more than minimal scarring at diagnosis. Documenting this provides a “baseline” ^[10]. This does not mean you will need regular, scheduled biopsies. Repeat biopsies are generally only performed if your symptoms, spleen size, or blood counts change significantly in the future ^[11].

Ruling Out “Mimics” Like Pre-PMF

A major reason for the biopsy is to rule out a closely related condition called pre-fibrotic primary myelofibrosis (pre-PMF) ^[5].

Pre-PMF is a distinct prefibrotic disease category that can look identical to ET on standard blood tests. Patients with pre-PMF also have high platelets and can carry the JAK2, CALR, or MPL mutations ^[1]. The only way to reliably tell them apart is by looking at the megakaryocyte cells in the bone marrow ^[5].

This distinction matters. Retrospective studies suggest that, as a group, patients with pre-PMF have a higher risk of eventually progressing to overt myelofibrosis (one study estimated a 31.3% risk over 10 years for pre-PMF compared to 13.7% for ET) ^[12]. While these cohort estimates do not dictate your individual future, knowing exactly which condition you have helps your care team choose the most appropriate risk assessment and monitoring schedule ^[13].

How the Tests Work Together

What if You Decline the Biopsy?

If you choose not to have a biopsy, your diagnosis will likely remain “provisional” rather than formal ^[2]. Your hematologist can often still monitor your blood counts, assess your risk of blood clots, and even start treatments to manage your platelets or symptoms based on this working diagnosis. However, without the biopsy, important information regarding the exact MPN subtype and your baseline scarring will remain unknown.

Preparing for the Procedure

If you decide to proceed, discuss the practicalities with your care team. A bone marrow sample is typically taken from the back of the hip bone. You may experience pressure and brief, temporary pain.

• Anesthesia and Sedation: Many centers offer local anesthesia, anti-anxiety medications, or even conscious sedation to make the procedure as comfortable as possible. Availability depends on the center and your specific health factors.
• Medications: Discuss your current medications with your team—especially aspirin or blood thinners. They will advise you on whether to continue or adjust them before the procedure. Do not stop them on your own.
• Recovery: Expect some soreness or bruising for a few days. Ask your doctor when you can resume normal activities (like work or exercise) and what signs (such as persistent bleeding, worsening pain, or fever) should prompt a call.